1. Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification
   Shuyue Fu et al, 2017, Expert Review of Proteomics CrossRef
2. Mechanisms of chemoresistance and approaches to overcome its impact in gynecologic cancers
   Nirupama Sabnis et al, 2021, Overcoming Drug Resistance in Gynecologic Cancers CrossRef
3. DNA methyltransferase inhibitors (DNMTis) as sensitizing agents to overcome chemoresistance
   Shini Liu et al, 2021, Epigenetic Regulation in Overcoming Chemoresistance CrossRef
4. Integrated miRNA-mRNA Analysis Reveals Potential Biomarkers of Chemoresistance in Ovarian Cancer
   Niping Liu et al, 2021, Journal of Biomaterials and Tissue Engineering CrossRef
5. Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer
   Bingbing Yan et al, 2020, Medicine CrossRef
6. A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer
   Peide Huang et al, 2021, Frontiers in Oncology CrossRef
7. UNBS5162 inhibits SKOV3 ovarian cancer cell proliferation by regulating the PI3K/AKT signalling pathway
   Qiang Wang et al, 2019, Oncology Letters CrossRef
8. Bioinformatics Accelerates the Major Tetrad: A Real Boost for the Pharmaceutical Industry
   Tapan Behl et al, 2021, International Journal of Molecular Sciences CrossRef
9. Successful treatment of ovarian cancer with apatinib combined with chemotherapy
   Mingzi Zhang et al, 2017, Medicine CrossRef
10. The role of DNA methylation in ovarian cancer chemoresistance: A narrative review
    Kaiyang Song et al, 2023, Health Science Reports CrossRef
11. Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer
    Hua Tian et al, 2019, Clinical Epigenetics CrossRef
12. Translational Bioinformatics Methods for Drug Discovery and Development
    Qing Yan, 2017, Translational Bioinformatics and Systems Biology Methods for Personalized Medicine CrossRef
13. A systematic literature review assessing if genetic biomarkers are predictors for platinum-based chemotherapy response in ovarian cancer patients
    Caitlin Phillips-Chavez et al, 2020, European Journal of Clinical Pharmacology CrossRef
14. A Retrospective Cross-Sectional Cohort Trial Assessing the Prevalence of MTHFR Polymorphisms and the Influence of Diet on Platinum Resistance in Ovarian Cancer Patients
    Caitlin Phillips-Chavez et al, 2021, Cancers CrossRef
15. Methylation and ovarian cancer: Can DNA methylation be of diagnostic use? (Review)
    Julie Hentze et al, 2019, Molecular and Clinical Oncology CrossRef
16. Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
    Li-yuan Feng et al, 2021, Clinical Epigenetics CrossRef